Winfried Edelmann

15.5k total citations · 1 hit paper
140 papers, 11.3k citations indexed

About

Winfried Edelmann is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Winfried Edelmann has authored 140 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 76 papers in Pathology and Forensic Medicine and 40 papers in Cancer Research. Recurrent topics in Winfried Edelmann's work include Genetic factors in colorectal cancer (74 papers), DNA Repair Mechanisms (53 papers) and Cancer Genomics and Diagnostics (27 papers). Winfried Edelmann is often cited by papers focused on Genetic factors in colorectal cancer (74 papers), DNA Repair Mechanisms (53 papers) and Cancer Genomics and Diagnostics (27 papers). Winfried Edelmann collaborates with scholars based in United States, Germany and Canada. Winfried Edelmann's co-authors include Raju Kucherlapati, Burkhard Kneitz, Kan Yang, Harry Hou, Uwe Werling, Martin Lipkin, Matthew D. Scharff, Yongwei Zhang, Xiao Lan Zhang and Michael P. Lisanti and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Winfried Edelmann

140 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities

2001 975 citations Harry Hou, Burkhard Kneitz et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Winfried Edelmann

Since Specialization

Citations

This map shows the geographic impact of Winfried Edelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winfried Edelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winfried Edelmann more than expected).

Fields of papers citing papers by Winfried Edelmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Winfried Edelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winfried Edelmann. The network helps show where Winfried Edelmann may publish in the future.

Co-authorship network of co-authors of Winfried Edelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Winfried Edelmann. A scholar is included among the top collaborators of Winfried Edelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Winfried Edelmann. Winfried Edelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease 2024 ·Brain ·(unknown), Edward J. Smith, Christian Landles, Georgina F Osborne, (unknown), (unknown), (unknown), Yongwei Zhang, Bo Jin, Marissa B. Hirst, Caroline Benn, Brian Bond, Winfried Edelmann, Jonathan Greene, Gillian P. Bates	21
2	Combined inhibition of MTAP and MAT2a mimics synthetic lethality in tumor models via PRMT5 inhibition 2023 ·Journal of Biological Chemistry ·(unknown), (unknown), (unknown), (unknown), Elena Tosti, Karl J. Shaffer, Peter C. Tyler, Winfried Edelmann, Leonard H. Augenlicht, Vern L. Schramm	15
3	Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173A mice 2022 ·Nucleic Acids Research ·Shanzhi Wang, (unknown), Stephen Gray, Yongwei Zhang, Catherine Tang, (unknown), Elena Tosti, (unknown), Mohammad Ruhul Amin, Paula E. Cohen, Thomas MacCarthy, Sergio Roa, Matthew D. Scharff, Winfried Edelmann, Richard Chahwan	12
4	Mutation of the ATPase Domain of MutS Homolog-5 (MSH5) Reveals a Requirement for a Functional MutSγ Complex for All Crossovers in Mammalian Meiosis 2019 ·G3 Genes Genomes Genetics ·(unknown), J. Kim Holloway, Yongwei Zhang, Bo Jin, Cameron Smith, Aviv Bergman, Winfried Edelmann, Paula E. Cohen	18
5	MSH2 Dysregulation Is Triggered by Proinflammatory Cytokine Stimulation and Is Associated with Liver Cancer Development 2016 ·Cancer Research ·Yuji Eso, Atsushi Takai, Tomonori Matsumoto, Tadashi Inuzuka, Takahiro Horie, Koh Ono, Shinji Üemoto, (unknown), Winfried Edelmann, Tsutomu Chiba, Hiroyuki Marusawa	24
6	A Novel Chemotherapeutic Agent to Treat Tumors with DNA Mismatch Repair Deficiencies 2016 ·Cancer Research ·Yongliang Zhang, Jennifer T. Fox, Young-Un Park, Gene Elliott, Ganesha Rai, Mengli Cai, Srilatha Sakamuru, (unknown), Menghang Xia, (unknown), Min Ho Jeon, Bijoy P. Mathew, (unknown), Winfried Edelmann, Chan Young Park, Sung You Hong, David J. Maloney, Kyungjae Myung	20
7	Chromatin remodeling enzyme Snf2h regulates embryonic lens differentiation and denucleation 2016 ·Development ·Shuying He, (unknown), Rebecca McGreal, Qing Xie, Lisa Brennan, (unknown), Juraj Kokavec, (unknown), Harry Hou, Winfried Edelmann, Wei Liu, Ruth Ashery‐Padan, Jiří Zavadil, Marc Kantorow, Arthur I. Skoultchi, Tomáš Stopka, Aleš Cvekl	43
8	A Functional Cancer Genomics Screen Identifies a Druggable Synthetic Lethal Interaction between MSH3 and PRKDC 2014 ·Cancer Discovery ·Felix Dietlein, Lisa Thelen, Mladen Jokić, Ron D. Jachimowicz, (unknown), Gero Knittel, Uschi Leeser, (unknown), Winfried Edelmann, Lukas C. Heukamp, Hans Christian Reinhardt	53
9	Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2 ^loxP/loxP Villin-Cre mice 2014 ·Gut ·(unknown), Christoph Campregher, Michaela Lang, Vineeta Khare, Matthias Pinter, Rayko Evstatiev, Gerald Schmid, Martina Mittlböck, Theresa Scharl, Melanie H. Kucherlapati, Winfried Edelmann, Christoph Gasché	26
10	Aspirin and Low-Dose Nitric Oxide–Donating Aspirin Increase Life Span in a Lynch Syndrome Mouse Model 2011 ·Cancer Prevention Research ·Michael A. McIlhatton, Jessica K. Tyler, Laura A. Kerepesi, Tina Bocker Edmonston, Melanie H. Kucherlapati, Winfried Edelmann, Raju Kucherlapati, Levy Kopelovich, Richard Fishel	34
11	A possible mechanism for exonuclease 1-independent eukaryotic mismatch repair 2009 ·Proceedings of the National Academy of Sciences ·Farid A. Kadyrov, Jochen Genschel, Yanan Fang, (unknown), Winfried Edelmann, Paul Modrich	112
12	An Msh2 Conditional Knockout Mouse for Studying Intestinal Cancer and Testing Anticancer Agents 2009 ·Gastroenterology ·Melanie H. Kucherlapati, (unknown), Andrew Nguyen, Allan Clark, Harry Hou, (unknown), Hua Li, Kan Yang, Kunhua Fan, Martin Lipkin, Roderick T. Bronson, Linda A. Jelicks, Thomas A. Kunkel, Raju Kucherlapati, Winfried Edelmann	77
13	Interaction of Muc2 and Apc on Wnt Signaling and in Intestinal Tumorigenesis: Potential Role of Chronic Inflammation 2008 ·Cancer Research ·Kan Yang, Н. В. Попова, Wancai Yang, (unknown), (unknown), (unknown), Laura Bancroft, Ilze Matise, Robert T. Cormier, Stefan Scherer, Winfried Edelmann, Martin Lipkin, Leonard H. Augenlicht, Anna Velcich	88
14	Dietary Induction of Colonic Tumors in a Mouse Model of Sporadic Colon Cancer 2008 ·Cancer Research ·Kan Yang, Naoto Kurihara, Kunhua Fan, Harold L. Newmark, Basil Rigas, Laura Bancroft, Georgia Corner, Elayne Livote, Martin Lesser, Winfried Edelmann, Anna Velcich, Martin Lipkin, Leonard H. Augenlicht	85
15	Ubiquitylated PCNA plays a role in somatic hypermutation and class-switch recombination and is required for meiotic progression 2008 ·Proceedings of the National Academy of Sciences ·Sergio Roa, Elena Avdievich, Jonathan U. Peled, Thomas MacCarthy, Uwe Werling, Fei Kuang, Rui Kan, Chunfang Zhao, Aviv Bergman, Paula E. Cohen, Winfried Edelmann, Matthew D. Scharff	94
16	An Msh2 Point Mutation Uncouples DNA Mismatch Repair and Apoptosis 2004 ·Cancer Research ·Diana P. Lin, Yuxun Wang, Stefan Scherer, Allan Clark, Kan Yang, Elena Avdievich, Bo Jin, Uwe Werling, Tchaiko Parris, Naoto Kurihara, Asad Umar, Raju Kucherlapati, Martin Lipkin, Thomas A. Kunkel, Winfried Edelmann	151
17	Spontaneous Aberrant Crypt Foci in Apc1638N Mice with a Mutant Apc Allele 2003 ·American Journal Of Pathology ·Theresa P. Pretlow, Winfried Edelmann, Raju Kucherlapati, Thomas G. Pretlow, Leonard H. Augenlicht	18
18	Cutting Edge: The G-U Mismatch Glycosylase Methyl-CpG Binding Domain 4 Is Dispensable for Somatic Hypermutation and Class Switch Recombination 2003 ·The Journal of Immunology ·Philip D. Bardwell, Alberto Martín, (unknown), Ziqiang Li, Winfried Edelmann, Matthew D. Scharff	38
19	Somatic Hypermutation in Muts Homologue (Msh)3-, Msh6-, and Msh3/Msh6-Deficient Mice Reveals a Role for the Msh2–Msh6 Heterodimer in Modulating the Base Substitution Pattern 2000 ·The Journal of Experimental Medicine ·Margrit Wiesendanger, Burkhard Kneitz, Winfried Edelmann, Matthew D. Scharff	159
20	Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. 1998 ·Europe PMC (PubMed Central) ·Wolfgang Liedtke, Winfried Edelmann, (unknown), Raju Kucherlapati, Cedric S. Raine	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact